Goldman’s profit roughly doubled in Q4 thanks in large part to surging revenues from deal-making, underwriting, and trading.
Goldman Sachs predicts a gradual recovery for Life Sciences Tools in 2025, with bioprocessing gaining traction and improved ...
Goldman Sachs analyst cuts ExxonMobil price forecast due to mark-to-market commodity prices, but maintains Neutral rating. Q4 ...
Goldman Sachs Group outperformed expectations in its fourth-quarter and full-year earnings with a robust financial showing ...
Goldman Sachs shares gained in premarket trading Wednesday after the bank reported better-than-expected fourth-quarter ...
Oppenheimer maintained its Outperform rating on Goldman Sachs (NYSE:GS) stock and increased the price target to $687 from the ...
Goldman Sachs stock is not overvalued as growth in revenue and EPS is impressive. Click here to find out why I believe GS is ...
JPMorgan Chase, Goldman Sachs, Citi and Wells Fargo all reported fourth-quarter earnings Wednesday, and each banking behemoth ...
Goldman Sachs reported on Wednesday higher fourth-quarter profit above market estimates, powered by strong growth in revenues ...
Goldman Sachs said its profit more than doubled in the fourth quarter, boosted by companies’ growing appetite for dealmaking.
Goldman Sachs BDC's portfolio has diversified sector exposure, with notable changes in exposure since last coverage. Read why ...
Analysis of JPMorgan Chase and Goldman Sachs Q4 2024 earnings forecasts, including key metrics, analyst expectations and ...